Michael Davis becomes Cyanotech chairman

Hawaiian microalgae technology company looks forward to continuing support of its major shareholder

Michael Davis has been elected as chairman of Hawaii-based Cyanotech Corporation. He replaces Gregg Robertson, who resigned in late 2010.

Davis was vice-chairman of the board and has been a director of Cyanotech since March 2003.

‘Michael has been a key influence in helping Cyanotech sharpen its business model and market focus in recent years,’ said Brent Bailey, president and ceo. ‘We look forward to his continuing support and leadership as chairman of the board.’

Cyanotech Corporation, a microalgae technology specialist, produces BioAstin Natural Astaxanthin and Hawaiian Spirulina Pacifica, which are natural, functional nutrients.

You may also like

Manufacturing

Cipla receives FDA approval for first AB-rated generic of Ventolin HFA in $1.5bn US albuterol market

Indian pharmaceutical company Cipla has secured final FDA approval for its Albuterol Sulfate Inhalation Aerosol, becoming the first AB-rated generic therapeutic equivalent of GlaxoSmithKline's Ventolin HFA
Ingredients

Pangea Pharmaceuticals launches FDA-approved amlodipine oral solution Sdamlo

Pangea’s Sdamlo, the first FDA-approved amlodipine powder for oral solution, leverages a patent-pending lyophilisation process to enable precise unit-dose delivery and improved administration for paediatric, geriatric and dysphagic patients
Ingredients

Oncodesign Services extends GIP ARRONAX collaboration to secure astatine-211 supply

The company has extended its collaboration with the French radionuclide specialist to secure access to astatine-211, an alpha-emitting radioisotope of growing interest in targeted radiotherapy but constrained by its seven-hour half-life and limited production capacity
Ingredients

Evaporation and lyophilization for converting RP-HPLC peptide fractions into stable powders

A method to obtain research peptides in a stable, dry, and contamination-free form for long-term storage
Ingredients

New ion chromatograph enhances water quality testing efficiency

Shimadzu’s Nexera IC combines automation and intuitive software to support reliable ion analysis and reduce laboratory workload
Ingredients

dsm-firmenich launches ModulaSENSE Bitter to tackle bitterness in oral drug formulations

The new taste modulation technology combines bitter blockers, maskers and sweeteners with receptor-based analysis to help pharmaceutical formulators improve the palatability of oral medicines
Manufacturing

Clariant opens first US pharmaceutical-grade PEG excipient manufacturing site in Texas

Clariant has expanded its Clear Lake facility in Texas to produce GMP-compliant pharmaceutical-grade polyethylene glycol excipients, marking its first US-based manufacturing site for the products and strengthening supply chain resilience for North American and Latin American pharma customers
Subscribe now